Honoring MOM: How far we've come
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
The use of real-world data has been gaining traction in the healthcare and life sciences...
In a world where precision medicines are becoming more and more common, and the development of...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "Zomb...